Neurodyn Inc.
Major Drugs - Charlottetown, PE, CA
Neurodyn Inc. Senior Management
Neurodyn Inc. Details
Alpha Cognition is a clinical stage, biopharmaceutical company dedicated to developing novel treatments for under-served neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis (ALS). ALPHA-1062, a patented new chemical entity that has demonstrated safety and improved tolerability in human clinical trials. It is being developed as a new acetylcholine esterase inhibitor for the treatment of dementia of the Alzheimer's type, with minimal gastrointestinal side-effects and novel routes of administration. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. It is in preclinical development for the treatment of ALS. ALPHA-0602 is patented and has received Orphan Drug Designation from the FDA.
Neurodyn Inc. Technologies
Email Providers
Outlook
CMS
WordPress.org
Fonts
Google Font API
Tag Management
Google Tag Manager
CSS and JavaScript Libraries
JQuery 1.11.1
Other
Mobile Friendly